SUNNYVALE, Calif., March 8 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. today announced that Richard A. Miller, M.D., president and CEO, will present at the Cowen and Company Annual Health Care Conference on Thursday, March 15, 2007 at 11:00 a.m. ET at The Boston Marriott Copley Place Hotel in Boston, MA.
A live webcast of Dr. Miller's presentation will be available on the events page of the Pharmacyclics website at http://ir.pharmacyclics.com/events.cfm and will be subsequently archived for 30 days. To access the live webcast, please log on to Pharmacyclics' site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.
About Pharmacyclics
Pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule drug development expertise to build a pipeline in oncology and other diseases based on a wide range of targets, pathways and mechanisms. Its lead product, Xcytrin(R), has completed Phase 3 clinical trials and is being studied as a single agent and in combination with chemotherapy and/or radiation in several ongoing Phase 1 and Phase 2 clinical trials in multiple cancer types. Pharmacyclics has other product candidates, including compounds and technology acquired from Celera Genomics, in earlier-stage development for cancer and other diseases. More information about the company, its technology, and products can be found at www.pharmacyclics.com. Pharmacyclics(R), Xcytrin(R) and the "pentadentate" logo(R) are registered trademarks of Pharmacyclics, Inc.
Pharmacyclics, Inc.CONTACT: Leiv Lea of Pharmacyclics, Inc., +1-408-774-0330; or AlineSchimmel of WeissComm Partners, +1-201-301-7218, for Pharmacyclics, Inc.
Web site: http://www.pharmacyclics.com//
